ARTIVION INC

AORT is the ticker symbol for Artivion, Inc., a medical device company traded on the New York Stock Exchange. The company focuses on products for aortic and cardiac surgery, including stent grafts, surgical sealants, and heart valve repair devices. AORT stock represents an ownership interest in this publicly traded business, allowing investors to participate in the company's financial performance and strategic developments within the cardiovascular medical device sector.

AORT operates in the medical device industry, specifically within cardiovascular and aortic surgical solutions. Artivion develops and markets products used in cardiac and vascular surgeries, such as aortic stent grafts, surgical sealants, and heart valve repair technologies. This industry is characterized by regulatory oversight, research and development intensity, and reliance on clinical adoption by hospitals and surgeons. Demand is often tied to procedure volumes and healthcare spending trends.

Recent price performance for AORT can be found in the latest quote and chart data displayed on this page. Performance may vary across daily, weekly, monthly, and year-to-date periods. For the most accurate and current information, review the price, percentage change, and historical price table shown above, as these figures update regularly during market hours and reflect actual trading activity.

The 52-week range shows the lowest and highest prices at which AORT has traded over the past year. This metric helps contextualize the current price relative to its annual trading history. You can find the exact 52-week high and low values in the stock data section on this page, which is updated with current market information.

Evaluating AORT's valuation typically involves examining metrics such as the price-to-earnings ratio, price-to-sales ratio, and enterprise value relative to EBITDA, alongside comparisons to peers in the medical device sector. Because AORT may have unique growth and profitability characteristics, it is important to review its financial statements and industry benchmarks. Current valuation ratios and peer comparisons are available in the financial data displayed on this page.

AORT does not currently pay a regular dividend, as Artivion focuses on reinvesting capital into research, development, and commercial expansion. Investors seeking income should verify the latest dividend status and any special distributions by checking the dividend section on this page, as corporate policies can change over time. For now, AORT is generally considered a non-dividend-paying stock.